Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angus G Jones

Showing results (21-30 of 97) with videos related to

Pageof 10
Sort By:
Plos One|April 7, 2016
Should Studies of Diabetes Treatment Stratification Correct for Baseline HbA1c?Angus G Jones, Mike Lonergan, William E Henley, et al.
Clinical Epidemiology|December 28, 2018
Evaluating associations between the benefits and risks of drug therapy in type 2 diabetes: a joint modeling approachJohn M Dennis, Beverley M Shields, Angus G Jones, et al.
BMC Medicine|April 14, 2019
What to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or continue? A MASTERMIND studyAndrew P McGovern, John M Dennis, Beverley M Shields, et al.
Pediatric Diabetes|November 25, 2021
Mortality amongst children and adolescents with type 1 diabetes in sub-Saharan Africa: The case study of the Changing Diabetes in Children program in CameroonJean Claude Katte, Gaelle Lemdjo, Mesmin Y Dehayem, et al.
Diabetes & Metabolic Syndrome|April 18, 2024
Performance of European prediction models for classification of type 1 and type 2 diabetes in IndiansUlagamadesan Venkatesan, Anandakumar Amutha, Angus G Jones, et al.
BMC Medical Informatics and Decision Making|June 16, 2023
Comparison of causal forest and regression-based approaches to evaluate treatment effect heterogeneity: an application for type 2 diabetes precision medicineAshwini Venkatasubramaniam, Bilal A Mateen, Beverley M Shields, et al.
Diagnostic and Prognostic Research|July 2, 2020
Logistic regression has similar performance to optimised machine learning algorithms in a clinical setting: application to the discrimination between type 1 and type 2 diabetes in young adultsAnita L Lynam, John M Dennis, Katharine R Owen, et al.
Diabetes Care|February 3, 2011
Urine C-peptide creatinine ratio is a noninvasive alternative to the mixed-meal tolerance test in children and adults with type 1 diabetesRachel E J Besser, Johnny Ludvigsson, Angus G Jones, et al.
Diabetes Research and Clinical Practice|July 24, 2020
Predicting post one-year durability of glucose-lowering monotherapies in patients with newly-diagnosed type 2 diabetes mellitus - A MASTERMIND precision medicine approach (UKPDS 87)Olorunsola F Agbaje, Ruth L Coleman, Andrew T Hattersley, et al.
Therapeutic Advances in Endocrinology and Metabolism|May 29, 2024
Phenotypic characterization of nonautoimmune diabetes in adult Ugandans with low body mass indexDavis Kibirige, Isaac Sekitoleko, William Lumu, et al.
Pageof 10

Showing results (21-30 of 97) with videos related to

Sort By:
Pageof 10
Plos One|April 7, 2016
Should Studies of Diabetes Treatment Stratification Correct for Baseline HbA1c?Angus G Jones, Mike Lonergan, William E Henley, et al.
Clinical Epidemiology|December 28, 2018
Evaluating associations between the benefits and risks of drug therapy in type 2 diabetes: a joint modeling approachJohn M Dennis, Beverley M Shields, Angus G Jones, et al.
BMC Medicine|April 14, 2019
What to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or continue? A MASTERMIND studyAndrew P McGovern, John M Dennis, Beverley M Shields, et al.
Pediatric Diabetes|November 25, 2021
Mortality amongst children and adolescents with type 1 diabetes in sub-Saharan Africa: The case study of the Changing Diabetes in Children program in CameroonJean Claude Katte, Gaelle Lemdjo, Mesmin Y Dehayem, et al.
Diabetes & Metabolic Syndrome|April 18, 2024
Performance of European prediction models for classification of type 1 and type 2 diabetes in IndiansUlagamadesan Venkatesan, Anandakumar Amutha, Angus G Jones, et al.
BMC Medical Informatics and Decision Making|June 16, 2023
Comparison of causal forest and regression-based approaches to evaluate treatment effect heterogeneity: an application for type 2 diabetes precision medicineAshwini Venkatasubramaniam, Bilal A Mateen, Beverley M Shields, et al.
Diagnostic and Prognostic Research|July 2, 2020
Logistic regression has similar performance to optimised machine learning algorithms in a clinical setting: application to the discrimination between type 1 and type 2 diabetes in young adultsAnita L Lynam, John M Dennis, Katharine R Owen, et al.
Diabetes Care|February 3, 2011
Urine C-peptide creatinine ratio is a noninvasive alternative to the mixed-meal tolerance test in children and adults with type 1 diabetesRachel E J Besser, Johnny Ludvigsson, Angus G Jones, et al.
Diabetes Research and Clinical Practice|July 24, 2020
Predicting post one-year durability of glucose-lowering monotherapies in patients with newly-diagnosed type 2 diabetes mellitus - A MASTERMIND precision medicine approach (UKPDS 87)Olorunsola F Agbaje, Ruth L Coleman, Andrew T Hattersley, et al.
Therapeutic Advances in Endocrinology and Metabolism|May 29, 2024
Phenotypic characterization of nonautoimmune diabetes in adult Ugandans with low body mass indexDavis Kibirige, Isaac Sekitoleko, William Lumu, et al.
Pageof 10